Lv61
2070 积分 2022-05-26 加入
Keverprazan Hydrochloride: First Approval
6小时前
已完结
Investigating Baxdrostat and Its Derivatives as Aldosterone Synthase Inhibitors for Resistant Hypertension: An In Silico Approach
15小时前
已完结
Investigating Baxdrostat and Its Derivatives as Aldosterone Synthase Inhibitors for Resistant Hypertension: An In Silico Approach
4天前
已完结
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
5天前
已完结
Aldosterone synthase inhibition: a novel bullet to fight cardiovascular–kidney–metabolic syndrome
5天前
已关闭
Aldosterone synthase inhibitors for the treatment of cardiovascular disease
5天前
已完结
Beyond Spironolactone: Does Next Generation of Aldosterone Blockade Add Value?
5天前
已完结
New drug therapies for hypertension
6天前
已完结
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial
7天前
已完结
New pharmacological therapies for hypertension
7天前
已完结
皖公网安备34019202002308
